The cumulative incidence of death from other causes was significantly higher in the ILA group (13.0% vs. 3.7%, p < 0.001), while lung cancer–related death did not differ significantly between groups (4.2% vs. 2.9%, p = 0.30) (Figure 5). The gene discussed is TNFRSF9; the disease is lung carcinoma.